APA

De Vos F. Y. F. L., Bos A. M. E., Schaapveld M., de Swart C. A. M., de Graaf H., van der Zee A. G. J., Boezen H. M., de Vries E. G. E. & Willemse P. H. B. (20050621). A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma. : Gynecologic oncology.

Chicago

De Vos F Y F L, Bos A M E, Schaapveld M, de Swart C A M, de Graaf H, van der Zee A G J, Boezen H M, de Vries E G E and Willemse P H B. 20050621. A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma. : Gynecologic oncology.

Harvard

De Vos F. Y. F. L., Bos A. M. E., Schaapveld M., de Swart C. A. M., de Graaf H., van der Zee A. G. J., Boezen H. M., de Vries E. G. E. and Willemse P. H. B. (20050621). A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma. : Gynecologic oncology.

MLA

De Vos F Y F L, Bos A M E, Schaapveld M, de Swart C A M, de Graaf H, van der Zee A G J, Boezen H M, de Vries E G E and Willemse P H B. A randomized phase II study of paclitaxel with carboplatin +/- amifostine as first line treatment in advanced ovarian carcinoma. : Gynecologic oncology. 20050621.